Cleared Traditional

K090223 - ICAD BREAST INTERVENTIONAL PLANNING SOF...

K090223 is an FDA 510(k) clearance for ICAD BREAST INTERVENTIONAL PLANNING SOF..., manufactured by Icad, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K090223 · Icad, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2009
Decision
60d
Days
Class 2
Risk

K090223 is an FDA 510(k) clearance for the ICAD BREAST INTERVENTIONAL PLANNING SOFTWARE, MODEL D70024. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Icad, Inc. (Nashua, US). The FDA issued a Cleared decision on March 31, 2009 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Icad, Inc. devices

FDA 510(k) Submission Details - K090223

510(k) Number K090223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 2009
Decision Date March 31, 2009
Days to Decision 60 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 107d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1193
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K090223.
NIO 2MP (MDNG-2121)
K091172 · Barco N.V. · May 2009
BARCO 5MP MAMMO, MODEL MDMG-5221
K090603 · Barco N.V. · Apr 2009
NIO COLOR 3MP AND MDNC-3121
K090732 · Barco N.V. · Apr 2009
UROCARE
K090552 · Neusoft Medical Systems Co., Ltd. · Mar 2009
MAMMODIAGNOST VU
K083740 · Philips Medical Systems Nederland B.V. · Feb 2009
COLOR LCD MONITOR, RADIFORCE RX320
K090045 · Eizo Nanao Corporation · Jan 2009